REQUEST A DEMO
Total
USD $0.00
Search more companies

Taeeung Pharm Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Taeeung Pharm Co.,Ltd. Profile Updated: December 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Taeeung Pharm Co.,Ltd. is an enterprise located in South Korea, with the main office in Siheung. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on January 01, 2009. Taeeung Pharm Co.,Ltd. currently employs 66 (2024) people. In 2021, the company reported a net sales revenue increase of 5.88%. Its’ total assets recorded a growth of 9.6%. In 2021, Taeeung Pharm Co.,Ltd.’s net profit margin increased by 0.32%.

Headquarters
Dumun-ro Siheung-si Gyeonggi, 18-2
Siheung; Gyeonggi; Postal Code: 429824

Contact Details: Purchase the Taeeung Pharm Co.,Ltd. report to view the information.

Website: http://www.taeeung.com/

Basic Information
Total Employees:
Purchase the Taeeung Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Taeeung Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Taeeung Pharm Co.,Ltd. report to view the information.
Incorporation Date:
January 01, 2009
Key Executives
Purchase this report to view the information.
CEO
Ownership Details
Purchase this report to view the information.
40.5%
Purchase this report to view the information.
39.2%
Purchase this report to view the information.
8.6%
Company Performance
Financial values in the chart are available after Taeeung Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
5.88%
Total operating revenue
5.88%
Operating profit (EBIT)
36.21%
EBITDA
35.95%
Net Profit (Loss) for the Period
40.37%
Total assets
9.6%
Total equity
23.53%
Operating Profit Margin (ROS)
0.38%
Net Profit Margin
0.32%
Return on Equity (ROE)
2.62%
Debt to Equity Ratio
-9.49%
Quick Ratio
0.07%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?